| Alkem Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 539523 |
NSE Symbol : ALKEM |
P/E(TTM) : 31.15 |
|
ISIN Demat : INE540L01014 |
Div & Yield% : 0.73 |
EPS(TTM) : 176.61 |
|
Book Value(₹) : 882.75 |
Market Cap(₹Cr) : 65,776.89 |
Face Value(₹) : 2.00 |
| Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
| Reserves | 10,530.70 | 9,325.94 | 8,719.75 | 7,601.84 | 6,256.53 |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Shareholders Funds | 10,554.61 | 9,349.85 | 8,743.66 | 7,625.75 | 6,280.44 |
| Secured Loans | 172.02 | 119.31 | 1,010.07 | 327.88 | 238.60 |
| Unsecured Loans | 833.19 | 1,062.38 | 1,283.71 | 1,055.63 | 970.78 |
| Total Debt | 1,005.21 | 1,181.69 | 2,293.78 | 1,383.51 | 1,209.38 |
| Other Liabilities | 339.19 | 291.48 | 263.91 | 197.35 | 239.31 |
| Total Liabilities | 11,899.01 | 10,823.02 | 11,301.35 | 9,206.61 | 7,729.13 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 3,144.31 | 2,932.25 | 2,826.98 | 2,481.89 | 2,351.73 |
| Less: Accumulated Depreciation | 1,362.07 | 1,107.16 | 944.91 | 723.53 | 514.97 |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Block | 1,782.24 | 1,825.09 | 1,882.07 | 1,758.36 | 1,836.76 |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Work in Progress | 90.78 | 228.75 | 232.45 | 323.26 | 313.66 |
| Investments | 2,828.98 | 3,005.55 | 2,528.61 | 2,152.38 | 1,956.04 |
| Current Assets, Loans & Advances | |||||
| Inventories | 1,849.56 | 1,724.66 | 1,975.73 | 1,513.26 | 1,092.58 |
| Sundry Debtors | 1,753.64 | 1,768.34 | 1,768.22 | 1,556.55 | 1,555.07 |
| Cash and Bank Balance | 1,065.85 | 2,163.87 | 2,297.21 | 1,673.36 | 765.61 |
| Loans and Advances | 3,227.27 | 802.75 | 684.29 | 726.20 | 654.40 |
| Total Current Assets | 7,896.32 | 6,459.62 | 6,725.45 | 5,469.37 | 4,067.66 |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 2,028.15 | 1,683.76 | 1,673.80 | 1,367.46 | 1,207.97 |
| Provisions | 110.64 | 224.44 | 194.02 | 198.66 | 168.73 |
| Total CL & Provisions | 2,138.79 | 1,908.20 | 1,867.82 | 1,566.12 | 1,376.70 |
| Net Current Assets | 5,757.53 | 4,551.42 | 4,857.63 | 3,903.25 | 2,690.96 |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Assets | 1,540.21 | 1,292.74 | 1,248.66 | 1,143.51 | 1,005.92 |
| Deferred Tax Liability | 253.55 | 207.82 | 199.92 | 189.08 | 186.76 |
| Net Deferred Tax | 1,286.66 | 1,084.92 | 1,048.74 | 954.43 | 819.16 |
| Other Assets | 152.82 | 127.29 | 751.85 | 114.93 | 112.55 |
| Total Assets | 11,899.01 | 10,823.02 | 11,301.35 | 9,206.61 | 7,729.13 |
| Contingent Liabilities | 100.88 | 289.52 | 274.92 | 287.75 | 278.73 |